188
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

What can be inferred if the fetal increased nuchal translucency thickness changes?

, , , , , , , , & show all
Pages 1080-1085 | Received 28 Apr 2018, Accepted 17 Aug 2018, Published online: 15 Nov 2018

References

  • Pandya PP, Snijders RJ, Johnson SP, et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. BJOG Int J Obs Gyn. 1995;102:957–962.
  • Sherer DM, Bombard AT, Kellner LH, et al. Noninvasive first-trimester screening for fetal aneuploidy. Obstet Gynecol Surv. 1997;52:123–129.
  • Hafner E, Schuchter K, Liebhart E, et al. Results of routine fetal nuchal translucency measurement at weeks 10–13 in 4233 unselected pregnant women. Prenat Diagn. 1998;18:29–34.
  • De Domenico R, Faraci M, Hyseni E, et al. Increased nuchal traslucency in normal karyotype fetuses. J Prenat Med. 2011;5:23–26.
  • Salman Guraya S. The associations of nuchal translucency and fetal abnormalities: Significance and implications. J Clin Diagn Res. 2013;7:936–941.
  • Roozbeh N, Azizi M, Darvish L. Pregnancy outcome of abnormal nuchal translucency: A systematic review. J Clin Diagn Res. 2017;11:QC12–QC16.
  • Goetzl L. Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy. Clin Lab Med. 2010;30:613–628.
  • Bijok J, Ziora-Jakutowicz K, Ilnicka A, et al. Increased nuchal translucency in chromosomally normal fetuses and pregnancy outcomes – a retrospective study. Ginekol Pol. 2013;84:172–179.
  • Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Lancet. 1998;352:343–346.
  • Sharifzadeh M, Adibi A, Kazemi K, et al. Normal reference range of fetal nuchal translucency thickness in pregnant women in the first trimester, one center study. J Res Med Sci. 2015;20:969–973.
  • Pajkrt E, de GIM, Mol BW, et al. Weekly nuchal translucency measurements in normal fetuses. Obstet Gynecol. 1998;91:208–211.
  • Zoppi MA, Ibba RM, Floris M, et al. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses. BJOG Int J Obs Gyn. 2003;110:584–588.
  • Socolov D, Socolov R, Gorduza VE, et al. Increased nuchal translucency in fetuses with a normal karyotype-diagnosis and management: an observational study. Medicine (Baltimore). 2017;96:e7521.
  • Souka AP, von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 2005;192:1005–1021.
  • Pan M, Han J, Zhen L, et al. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray. Eur J Obstet Gynecol Reprod Biol. 2016;197:164–167.
  • Sun Q, Xu J, Hu SQ, et al. Distribution and normal reference range of fetal nuchal translucency thickness in Kunming pregnant women in the first trimester. Zhonghua Fu Chan Ke Zhi. 2012;47:514–517.
  • Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304:867–869.
  • Taipale P, Hiilesmaa V, Salonen R, et al. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med. 1997;337:1654–1658.
  • Maymon R, Jauniaux E, Cohen O, et al. Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency. Hum Reprod. 2000;15:2023–2027.
  • Tahmasebpour A, Rafiee NB, Ghaffari S, et al. Increased nuchal translucency and pregnancy outcome. Iran J Public Health. 2012;41:92–97.
  • Böhlandt S, von Kaisenberg CS, Wewetzer K, et al. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod. 2000;15:1155–1158.
  • von Kaisenberg CS, Prols F, Nicolaides KH, et al. Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency. Hum Reprod. 2003;18:2544–2561.
  • Leung TY, Vogel I, Lau TK, et al. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol. 2011;38:314–319.
  • Yang X, Li R, Fu F, et al. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype. J Matern Fetal Neonatal Med. 2017;30:194–198.
  • Huang J, Poon LC, Akolekar R, et al. Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH? Ultrasound Obstet Gynecol. 2014;43:620–624.
  • Hyett JA, Brizot ML, Von Kaisenberg CS, et al. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol. 1996;87:506–510.
  • Ludford I, Scheil W, Tucker G, et al. Pregnancy outcomes for nulliparous women of advanced maternal age in South Australia, 1998–2008. Aust N Z J Obstet Gynaecol. 2012;52:235–241.
  • Pan M, Han J, Yang X, et al. A 1st-trimester combined screening test in pregnant women of advanced maternal age in a Chinese population. J Obstet Gynaecol. 2015;35:121–124.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.